Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

152

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N02CD01	AIMOVIG	BioTech	Erenumab - 70mg/ml	70mg/ml	Injectable solution	35,423,371 L.L
N02CD02	EMGALITY	BioTech	Galcanezumab - 120mg/ml	120mg/ml	Injectable suspension	37,250,732 L.L
N02CX01	APIZINE	G	Pizotifen - 0.25mg/5ml	0.25mg/5ml	Syrup	505,541 L.L
N03AA02	GARDENAL	B	Phenobarbital - 100mg	100mg	Tablet	120,946 L.L
N03AB02	EPANUTIN	B	Phenytoin sodium - 100mg	100mg	Capsule	739,113 L.L
N03AB02	EPANUTIN	B	Phenytoin sodium - 100mg	100mg	Capsule	739,113 L.L
N03AB02	PHENTOLEP INJECTION	G	Phenytoin (sodium) - 250mg/5ml	250mg/5ml	Injectable solution	1,447,318 L.L
N03AB02	? PHENYTOIN SODIUM 5% USP	G	Phenytoin (sodium) - 250mg/5ml	5ml	Injectable solution	276,448 L.L
N03AE01	RIVOTRIL	B	Clonazepam - 0.5mg	0.5mg	Tablet, scored	403,153 L.L
N03AE01	RIVOTRIL	B	Clonazepam - 2mg	2mg	Tablet, scored	503,941 L.L
N03AF01	APO-CARBAMAZEPINE	G	Carbamazepine - 200mg	200mg	Tablet	727,019 L.L
N03AF01	NEUROTOP RETARD	G	Carbamazepine - 600mg	600mg	Tablet, prolonged release	1,569,608 L.L
N03AF01	NEUROTOP RETARD	G	Carbamazepine - 300mg	300mg	Tablet, prolonged release	931,283 L.L
N03AF01	TEGRETOL	B	Carbamazepine - 2%	2%	Suspension	456,906 L.L
N03AF04	ZEBINIX	B	Eslicarbazepine acetate - 800mg	800mg	Tablet	11,123,961 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 200mg/3.47ml	200mg/3.47ml	Syrup	442,124 L.L
N03AG01	CONVULEX	G	Sodium Valproate - 50mg/ml	50mg/ml	Syrup	213,671 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 200mg/ml	200mg/ml	Solution	360,150 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 500mg	500mg	Tablet, enteric coated	479,752 L.L
N03AG01	CONVULEX	G	Sodium Valproate - 300mg/ml	300mg/ml	Solution	1,018,633 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 200mg	200mg	Tablet, enteric coated	240,548 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 400mg	400mg	Injectable lyophilised powder for solution+diluent	450,187 L.L
N03AG01	DEPAKINE CHRONO	B	Valproic acid - 145mg, Sodium Valproate - 333mg	500mg	Tablet, coated, scored, prolonged release	362,837 L.L
N03AG01	CONVULEX RETARD	G	Sodium Valproate - 500mg	500mg	Tablet, prolonged release	423,310 L.L
N03AG01	VALPROATE DE SODIUM ARROW LP	G	Sodium valproate - 500mg	500mg	Tablet, coated, scored, prolonged release	253,986 L.L
N03AG01	VILAPRO CHRONO 500	G	Sodium valproate - 333mg, Valproic acid - 145mg		Tablet, film coated, prolonged release	217,702 L.L
N03AG01	CONVULEX	G	Sodium valproate - 100mg/ml	100mg/ml	Injectable solution	4,441,399 L.L
N03AG04	SABRIL	B	Vigabatrin - 500mg	500mg	Tablet, film coated	2,988,706 L.L
N03AX09	LAMOTRIGINE ARROW LAB	G	Lamotrigine - 100mg	100mg	Tablet, dispersible/ chewable	1,050,885 L.L
N03AX09	LAMOTRIGINE BIOGARAN	G	Lamotrigine - 100mg	100mg	Tablet, dispersible	1,233,647 L.L

...

152

...